PHILADELPHIA (February 21, 2017)— Eric M. Horwitz, MD, chair of the Department of Radiation Oncology at Fox Chase Cancer Center, has been selected by the American Brachytherapy Society (ABS) as an inaugural ABS Fellow. He will be formally recognized at the ABS 2017 Annual Conference in Boston in April.
In nearly 20 years at Fox Chase he has guided the growth of the Radiation Oncology Department in both size and impact. Under Horwitz’s leadership, Fox Chase has notably expanded its radiation oncology treatment options and patient volumes. His achievements include implementation of an MRI treatment simulator into prostate cancer treatment, and making Fox Chase the first in the northeastern United States to offer High Dose Rate (HDR) brachytherapy implants to men with prostate cancer. Since 2009 Horwitz has held the Gerald E. Hanks Chair in Radiation Oncology.
Horwitz is a past president and board chair of ABS, and he currently serves on the editorial board of its journal, Brachytherapy.
“This is a tribute to Dr. Horwitz’s fine career and his contributions to the field of brachytherapy and to the ABS,” said Steven Frank, MD, president of the American Brachytherapy Society.
Horwitz is one of 12 fellows in the inaugural class. His prior honors include appearing in Philadelphia magazine’s Top Docs consecutively for more than a decade, and he was most recently recognized in America’s Top Doctors® 2016.